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Purpose.  This study evaluates a pilot implementation of the Liverpool Care Pathway (LCP), 
a clinical tool used to guide the care of dying patients in the last days of life, on the end of life 
care for dying patients in three regions in rural Australia.    
Methods.  The LCP was implemented at thirteen participating sites:  nine hospitals (general 
wards), one community-based palliative care service, and three in-hospital palliative care 
units. To evaluate the implementation of the LCP, 415 eligible patient records were 
examined: 223 Pre-implementation and 192 Post-implementation (116 on the LCP and 76 
receiving usual care). The primary analysis compared all patients Pre-implementation of the 
LCP versus all patients Post-implementation.  
Results.  Increases were found Post-implementation for communication with other health 
professionals and with patients or family (Pre-69%, Post-87%; p=<0.000), use of palliative 
medications (Pre-87%, Post-98%; p=<0.000) and frequency of symptom assessments (Pre-
66%, Post-82%; p=<0.000).  Fewer blood and radiological investigations were conducted and 
venous access devices used in the Post-implementation groups than in the Pre-
implementation period.  
Conclusions.  This study suggests that when rigorously implemented, the LCP improves 









 In Australia in 2010 and 2011, 52% of deaths occurred in a hospital (including 
hospices affiliated with hospitals).[1] Estimates suggest that almost three quarters of deaths 
could be anticipated.[2]  However, one study found that that only 30 to 40 percent of these 
patients had any contact with a specialist palliative care service.[3]  Consequently, the 
majority of terminally ill patients are managed by non-specialist palliative care clinicians.[4, 
5]  The literature suggests that many non-palliative care clinicians lack experience in 
managing end-of-life symptoms. In addition, recognition of the dying phase often occurs very 
close to death (commonly only 24 to 48 hours before death) and specialist palliative care 
input, particularly out of hours, is not always readily available.[6, 7]    
Integrated care pathways (ICPs) are a popular strategy for fostering the use of evidence-
based clinical practice guidelines and reducing medical errors.[8, 9]  The Liverpool Care 
Pathway (LCP) is an end-of-life ICP based on the hospice model of care for use in the acute 
care setting. It was designed to improve the organisation and quality of palliative care in the 
last days of life through best practice comfort measures, symptom control, psychological and 
spiritual support, communication with family and the primary healthcare team, and 
documentation of the care provided.[10, 11] Previous studies have shown that end-of-life 
ICPs, particularly the LCP, are generally well regarded by health care professionals and are 
perceived to improve the care of dying patients, particularly with regard to symptom control, 
communication and documentation of care.[12-26] The LCP is now used in over 20 countries 
worldwide.[27] 
Nevertheless, the evidence supporting the LCP’s effectiveness in obtaining a good 
death remains equivocal.[28-31] For example, in the only cluster randomised trial of the LCP, 
Constantini et al.[32] found improvements in dignity, respect, kindness and the control of 
breathlessness, and an increased use of opioids and medications for pulmonary secretions. 
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However, they found no significant difference in overall quality of care toolkit scores 
between cancer patients who died in wards in which LCP had been implemented and those in 
which it had not. 
Recent well-publicised instances where end-of-life ICPs appear to have been misused 
have created controversy around the LCP in the UK.[33-35]  An independent review of the 
public’s concerns about the LCP concluded that, when applied correctly, the Liverpool Care 
Pathway helps generalist clinicians provide a dignified and pain-free death to their patients, 
supporting the principles underpinning the guidelines.  Nevertheless, the questions raised by 
the inquiry resulted in the Panel recommending that the LCP be replaced by an  
individualized end-of-life care plan for each patient.[36]  This study aimed to evaluate 
changes in the use of diagnostic and therapeutic interventions, clinical assessments and 
communication by health professionals with other clinicians, patients and families in a 
heterogeneous sample of patients in rural Western Australia (WA).  
METHODS 
A team of senior general and palliative care nurses, doctors and managers collaborated 
to modify the LCP Version 11 for the WA context.  With the permission of its originators, the 
hospital, hospice, community and care home versions of the LCP were standardised, and 
minor amendments were made to the terminology to address the cultural differences. For 
example, goal 6 was modified from discussing chaplain/religious advisors (original version 
11) to spiritual/religious advisors in the WA version. The modified LCP was then piloted in 
four palliative care services in urban WA to determine its suitability to WA and to inform the 
future state-wide implementation. Initial feasibility work conducted prior to the evaluation 
highlighted the need for a systematic approach to implementation, with training support for 
service providers throughout the intervention period.  The results reported here are derived 
from a second phase implementation of the LCP in 13 health care sites in rural WA. Specific 
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comparisons were performed between patients who died in hospitals in the eleven months 
prior to the implementation of the LCP (Pre-LCP) and patients who died while on the LCP in 
the first seven months after the implementation of the LCP; e.g., Post-LCP and a 
contemporaneous cohort of patients who died in the same seven months post-implementation, 
but were not formally cared for on the LCP (Not-LCP) 
The intervention was managed by a centralised group of experts coordinated through 
the WA Department of Health’s Palliative Care Network to ensure up to date, consistent and 
ongoing education of providers, support and guidance during implementation. Ethics 
approval was obtained from the WA Country Health Service (Ref. No. 2009:10), Edith 
Cowan University Human Subjects Review (Ref. No. 3992), and St. John of God Health Care 
ethics committees (Ref. No. 357). Due to the potential for causing distress for the patient 
prior to death, and bereaved family members after the death, the ethics committees granted 
approval to waive consent.  
Setting.  As a pragmatic capacity building project, all rural health services, including 
palliative care providers, which had not previously used the LCP, were invited to participate. 
Thirteen sites agreed to take part in the pilot: 9 community hospitals, 1 community palliative 
care service and 3 in-hospital palliative care units.   
Eligibility criteria.  Patients were eligible for inclusion in the data collection if they 
were 18 years or older and did not die within 24 hours of hospital/clinical site admission. Pre-
intervention medical record data collection occurred between January 1, 2009 and November 
30, 2009.  Intervention data was collected between December 1, 2009 and June 30, 2010. All 
patients who were expected to die within 72 hours at participating sites were the target for the 
intervention. Eligible patients (i.e., those identified as dying by clinical staff), in collaboration 
with their families (where appropriate), were offered the opportunity to be cared for 
according to the LCP. Only one patient refused the LCP and was cared for using standard 
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practices.  Patients in the Post Not-LCP group were cared for using ‘standard care’ and were 
included in the medical record data abstraction based on study eligibility. However, due to 
limitations of staff in these rural communities, patients in the LCP and Not-LCP groups were 
often cared for by the same clinical teams.  
Determination of LCP and Not-LCP patients.  As recommended by the developers of 
the LCP, introduction of the LCP was left to the discretion of the most senior clinician 
managing each patient.[11] As a result, some patients who died in the demonstration wards 
were not offered the LCP. While we were unable to collect observational data on team 
interaction regarding commencing the LCP, anecdotal information from the clinicians 
involved suggested that reasons for this included: 1) disagreement within the clinical team as 
to whether the patient was dying; 2) a last attempt at rescue before offering the LCP; or 3) 
clinical over-estimation of survival time left to the patient.  This cohort of patients thus 
formed a ‘natural’ contemporaneous comparison group which served as our control (Not-
LCP).  
 Implementation. The project used a participatory action research approach [37] and 
the Plan-Do-Study-Act quality improvement implementation methodology.[38] A multi-
disciplinary “train the trainer” approach was adopted with a minimum of two senior nurses 
from each site to manage the implementation.  Three methods of collaboration were used to 
train health professionals in quality improvement techniques and the LCP: 1) three structured 
training sessions (14 hours total) conducted over 12 months for both site champions and other 
participating health professionals; 2) monthly ‘coaching’ telephone, video conference calls or 
site visits by the implementation team to address concerns with the LCP implementation and 
to provide support; and, 3) monthly quality improvement data collection and feedback to 
teams on performance in implementing changes in practice based on the LCP goals of care. 
Training focused on clinical aspects of end-of-life care, communication skills development 
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between clinicians and patients and family members with clinicians, and education on the 
clinical use of the LCP. A palliative care resource kit was provided to the LCP champions at 
the first training session.[39] 
 Data collection.  Information regarding all care provided during the last 
hospitalisation was extracted from the medical records of eligible patients.  All treatment and 
procedure items were classified according to broad therapeutic categories and the expected 
direction of changes in outcomes as a result of the use of the LCP were identified by a panel 
of palliative care clinicians (two physicians, two nurses and one pharmacist) and the research 
team (Table 1).  






family, other clinicians  
Evidence of ≥ one medical or nursing contact and discussions with the 
patient’s GP and family within last 72 hours of life 
Ongoing symptom 
assessments   
4 hrly assessments of pain, agitation, respiratory tract secretions, 
dyspnoea, nausea & vomiting, psychological/spiritual issues conducted 




anticholinergics, etc.  
 
Prescription and ≥ one administration of a palliative medication for 
terminal comfort during last 72 hours of life e.g. of opioids, 
anticholinergics, antiemetics, anxiolytics 
Use of venous access 
device   
Peripheral intravenous/central venous catheter access device inserted or in 
place in last 72 hours 
Gastroenterology 
procedures   
Gastroenterological tube (e.g. nasogastric tube, percutaneous  endoscopic 
gastrostomy tube,  gastrojejunostomy feeding tube) inserted or in place in 
last 72 hours 
Oxygen therapy 
 
Use of oxygen therapy via nasal prongs, mask, CPAP, etc (excluding  
ventilated) 
Allied Health Interventions  
e.g. Speech, OT, 
Physiotherapy, Dietician 
or  
Access to speech therapist, occupational therapist, physiotherapist or 
dietician 
Blood Investigations e.g., 
urea, electrolytes, full 
blood picture 
 Any blood investigations undertaken in last 72 hours 
Drainage  e.g., pleural tap, 
ascites tap or  
Any drainage tube  e.g., pleural tap, ascites tap, urinary catheterisation 
inserted or in place in last 72 hours 
Radiology Investigations 
e.g., x ray, ultra-sound  
Any  radiology investigations undertaken in last 72 hours e.g., x ray, ultra-
sound  
 expected increase in use of this therapy or aspect of care 
 expected decrease in use of this therapy or aspect of care  




Sample Size.  Sample size was constrained by the number of eligible deaths at the 
selected sites. A sensitivity power analysis showed that at the 5% significance level, the 
available data was sufficient to provide at least 80% power to detect a 10% difference for the 
comparison between Pre-implementation and Post-implementation samples.   
 Data analysis.  The primary outcome measures were: utilisation of invasive medical 
investigations/interventions, symptom management and assessment, communication with 
patient/family and among health professionals. Outcome variables were dichotomous (i.e., 
yes/no) with patients deemed as having a procedure (yes) if there was documentation in the 
medical records of that procedure having been conducted within 72 hours of death. Chi-
square analyses were used to assess between-group differences. The primary analysis was all 
patients Pre-implementation of the LCP versus all patients Post-implementation. Secondary 
analyses were undertaken to assess the effect of the formal use of the LCP compared to being 
cared for by staff who may have received the LCP training without using the LCP formally. 
These involved comparing Pre vs LCP; Pre vs Post-Not LCP and LCP vs Post-Not LCP.  
Differences in baseline characteristics were assessed by examining descriptive statistics such 
as frequencies, means and standard deviations, or medians and interquartile ranges, as 
appropriate. All analyses were performed using SPSS: Version 17 or higher. 
RESULTS 
There were 415 eligible deaths over the data collection period. Of these, 223 occurred 
in the Pre-LCP period and 192 in the Post-implementation period. Of the Post-
implementation deaths, 116 (60%) were cared for using the LCP and 76 (40%) received 
‘usual’ care (Not-LCP group).  
 Patient Characteristics. The mean age of patients was 77.1 years (95% CI: 76.0 to 
78.3), the majority were male (54%) and had a non-cancer diagnoses (63%) (Table 2).  On 
average, patients were hospitalised for 11.9 days prior to death (95% CI: 10.1 to 13.4), with 
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59% having a length of stay of less than one week.  More patients died of non-cancer 
illnesses in the LCP and Not-LCP groups than in the Pre-LCP group (69% and 58% vs 54%; 
p=0.023).  Deaths were not evenly distributed between the sites during the study period.  The 
number of deaths per site ranged from 1 to 54 in the Pre-implementation period and 1 to 45 in 
the Post-implementation period, with substantial differences between the Pre and Post-
implementation periods at some sites.  For example, one of the larger sites contributed 29 
cases to the Pre-LCP group, but only 16 to the Post-implementation cohorts: 2 in the LCP 
group and 14 in the Not-LCP group.  Five sites contributed ≤5 cases to the LCP group, and 
nine sites contributed ≤5 cases each to the Not-LCP group. 
 
Table 2: Patient Characteristics by Pre and Post: LCP and Not-LCP 
 All 
patients Pre Post LCP Not-LCP p  
Age      
 Mean (years) 77.1 77.6 76.4 77.0  









Gender  n(%)      
 Male 176 (42) 96 (43) 48 (41) 32 (42)  
 Female 226 (54) 121 (54) 64 (55) 41 (54)  
 Unknown 13 (3) 6 (3) 4 (3) 3 (4) 0.982b 
Diagnosis  n(%)      
 Cancer 155 (37) 70 (31) 53 (46) 32 (42)  
 Non cancer 260 (63) 153 (69) 63 (54) 44 (58) 0.023b* 
Length of Stay      
 Mean (days) 11.9 12.1 10.6 13.3  









NB: Numbers may differ due to missing data. 
* Significance assessed at alpha=.05 
a
 analysis using ANOVA 
b
 analysis using Chi-Square statistic 
 
Length of Time on the LCP.  For patients cared for on the LCP, the mean number of 
days on the LCP prior to death was 4.2 days (95% CI: 3.4 to 4.9; median 3 days, IQ range 4).  
Mean length of time on the LCP for cancer patients was 3.8 days (95% CI: 2.9 to 3.7) while 
for non-cancer patients, mean length of time on the LCP was 4.4 days (95% CI: 3.2 to 5.7).  
These differences were not significant. 
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Overall Comparison of Use of Interventions Pre and Post-implementation of LCP. 
Communication with family members and other clinicians (p=<0.001), routine symptom 
assessment (p=<0.001) and pre-emptive prescribing of end-of-life medications (p=<0.001) 
improved in all patients in the Post-implementation period (Table 3).  
 
Table 3. Comparison of use of interventions for all patients in the last 72 hours life, 
Pre versus Post-implementation of LCP 
 
Medical Procedures 
Pre  Post  Chi 
square p n %  n %  
Communication with family, other 
clinicians 153 (69)  172 (87)  26.772 <0.001* 
Ongoing symptom assessments e.g., pain 
other symptoms 147 (66)  158 (82)  14.197 <0.001* 
Palliative medications 
prescribed/administered e.g., opioids, 
anticholinergics, etc.  
193 (87)  188 (98)  17.731 <0.001* 
Use of venous access device e.g., 
intravenous/central venous catheter  46 (21)  34 (18)  0.565   0.452 
Blood Investigations e.g., urea, 
electrolytes, full blood picture 53 (24)  36 (19)  1.541   0.214 
Radiology Investigations e.g., x ray, ultra-
sound 50 (22)  30 (16)  3.036   0.080 
Gastroenterology procedures 1 (0.4)  1 (.5)  0.011   0.915 
Oxygen therapy 43  (19)  39 (20)  0.069   0.793 
Allied Health Interventions  e.g. Speech, 
OT, Physiotherapy, Dietician 31 (14)  34 (18)  1.132   0.287 
Drainage e.g. pleural tap, ascites tap 33 (15)  29 (54)  0.008   0.931 
*Significance assessed at alpha=.05 
 
Comparison of Use of Interventions Pre and LCP.  Use of venous access devices 
(p=0.017), blood investigations (p=0.018), and radiological investigations or treatments 
(p=0.012) were lower in the LCP group when compared to the Pre-LCP group.   In addition, 
routine symptom assessment (p=0.006), pre-emptive prescribing of end-of-life medications 
(p=0.001) and communication with family and other clinicians (p=<0.001) were higher in the 





Table 4: Patients receiving interventions in the last 72 hours life, Pre versus LCP  
 
Medical Procedures 
Pre  LCP  Chi 
square 
  p n %  n %  
Communication with family, other 
clinicians 153 (69)  101 (87)  13.840 <0.001* 
Ongoing symptom assessments e.g., pain 
other symptoms 147 (66)  93 (80)  7.498 0.006* 
Palliative medications 
prescribed/administered e.g., opioids, 
anticholinergics, etc.  
193 (87)  113 (97)  10.255 0.001* 
Use of venous access device e.g., 
intravenous/central venous catheter  46 (21)  12 (10)  5.689 0.017* 
Blood Investigations e.g., urea, 
electrolytes, full blood picture 53 (24)  15 (13)  5.587 0.018* 
Radiology Investigations e.g., x ray, ultra-
sound 50 (22)  13 (11)  6.343 0.012* 
Gastroenterology procedures 1 (0.4)  0 (0)  0.522  0.470 
Oxygen therapy 43  (19)  18 (16)  0.733  0.392 
Allied Health Interventions  e.g. Speech, 
OT, Physiotherapy, Dietician 31 (14)  19 (16)  0.373  0.542 
Drainage e.g. pleural tap, ascites tap 33 (15)  16 (14)  0.062  0.803 
*Significance assessed at alpha=.05 
Comparison of Use of Interventions in Post Cohorts.  The use of venous access 
devices (p=0.001), blood investigations (p=0.011) and radiology investigations (p=0.037) 
were lower in the LCP group than in the Not-LCP group (Table 5).  Contrary to expectations, 
the use of oxygen appears higher in the Not-LCP group than in the LCP group.  Conversely, 
communication, ongoing symptom assessments and the use of palliative medications were not 












LCP  Not-LCP  Chi 
square 
 
p n %  n %  
Communication with family, other 
clinicians 101 (87)  71 (93)  1.985 0.159 
Ongoing symptom assessments e.g., pain 
other symptoms 93 (80)  65 (86)  0.903 0.342 
Palliative medications 
prescribed/administered e.g., opioids, 
anticholinergics, etc.  
113 (97)  75 (99)  0.363 0.547 
Use of venous access device e.g., 
intravenous/central venous catheter  12 (10)  22 (29)  10.904   0.001* 
Blood Investigations e.g., urea, electrolytes, 
full blood picture 15 (13)  21 (28)  6.513   0.011* 
Radiology Investigations e.g., x ray, ultra-
sound 13 (11)  17 (22)  4.339   0.037* 
Gastroenterology procedures 0 (0)  1 (1)  1.534   0.215 
Oxygen therapy 18 (16)  21 (28)  4.163 0.041 
Allied Health Interventions  e.g. Speech, 
OT, Physiotherapy, Dietician 19 (16)  15 (20)  0.355 0.551 
Drainage e.g. pleural tap, ascites tap 16 (14)  13 (17)  0.393 0.531 
*Significance assessed at alpha=.05 
 
Comparison of Use of Interventions Pre versus Not-LCP.  The comparison between 
the Pre and the Not-LCP groups showed no substantive reduction in invasive medical 
procedures.  In particular, there were no significant differences in the use of venous access 
devices, blood or radiology investigations (Table 6).  However, communication with family 
and other clinicians (p=<0.001), ongoing symptom assessments (p=0.001), and use of 



















square       p n %  n %  
Communication with family, other clinicians 153 (69)  71 (93)  18.568 <0.001* 
Ongoing symptom assessments e.g., pain 
other symptoms  147 (66)  65 (86)  10.562   0.001* 
Palliative medications 
prescribed/administered e.g., opioids, 
anticholinergics, etc.  
193 (87)  75 (99)  8.95 0.003* 
Use of venous access device e.g., 
intravenous/central venous catheter  46 (21)  22 (29)  2.233     0.135 
Blood Investigations e.g., urea, electrolytes, 
full blood picture 53 (24)  21 (28)  0.455      0.50 
Radiology Investigations e.g., x ray, ultra-
sound 50 (22)  17 (22)  0.000       0.992 
Gastroenterology procedures 1 (0.4)  1 (1)  0.642    0.423 
Oxygen therapy 43 (19)  21 (28)  2.349    0.125 
Allied Health Interventions  e.g. Speech, OT, 
Physiotherapy, Dietician 31 (14)  15 (20)  1.483    0.223 
Drainage e.g. pleural tap, ascites tap 33 (15)  13 (17)  0.232   0.630 
*Significance assessed at alpha=.05 
 
DISCUSSION  
We evaluated changes in the use of diagnostic and therapeutic interventions, clinical 
assessments and communication by health professionals with other clinicians, patients and 
families when the LCP was introduced into multiple health services in rural Western 
Australia. We found that the overall training program and implementation of the LCP 
resulted in an increase in communication with family members and other clinicians; routine 
symptom assessment; and, pre-emptive prescribing of end-of-life medications.   
We also found that the formal implementation of the LCP and care of patients using the 
LCP document resulted in a decrease in the use of invasive medical procedures and an 
increase in the documentation of assessments, coupled with an increase in the use of 
palliative medications. The LCP is intended to reduce the number of inappropriate or 
unnecessary procedures and treatments while increasing appropriate end-of-life care. These 
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findings suggest that there was an overall improvement in end-of-life care, with a strong 
focus on symptom relief. From this perspective, the implementation in WA was successful in 
achieving the goals of the LCP. 
Consistent with expectations, three important domains of potential active treatment (use 
of venous access devices, blood investigations, and radiology investigations) were 
significantly lower in the LCP group than in the Pre-LCP and Not-LCP groups. On the other 
hand, the Not-LCP group did not differ significantly from the Pre-LCP group on these 
domains. This suggests that the difference between the LCP and Not-LCP groups were not 
due to any secular or seasonal trends. Contrary to expectations, however, communication, 
ongoing assessments, and the use of palliative medications increased not only in the LCP 
group but also in the Not-LCP patients.   
The use of oxygen therapy appeared to be substantially higher in the Not-LCP group 
than in the LCP group. This was also the case when the Not-LCP group was compared to the 
Pre-LCP group, although this difference did not meet the standard for statistical significance. 
On the other hand, the LCP group did not differ significantly from the Pre-LCP on this 
domain. This finding, therefore, may be an anomaly resulting from small numbers.  
The current research literature shows some improvement in the care of the dying when 
using the LCP, particularly as a result of the structured prompts for the goals of care.  In our 
study, 60% of Post-implementation deaths were cared for on the LCP.  Previous studies 
report variable usage of the LCP ranging from 34% to 87%).[16, 17, 22-25]  Patients on the 
LCP in this study were cared for using the LCP for an average of 4.2 days (median 3 days), 
with no difference in length of time using the LCP for cancer and non-cancer patients.  This 
is longer than in much of the literature. For example, Veerbeek et.al., (2008) found a median 
duration of 63 hours on the LCP in home care, 35 hours in the nursing home, and 16 hours in 
the hospital.[24] Consistent with Constantini et al., we found that the administration of 
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potentially appropriate palliative medications, such as opioid and anticholinergics, increased 
in the Post-implementation groups. However, unlike Costantini, we found that documentation 
of communication with family members and between clinicians improved in the post-
implementation groups.  
Finally, participating sites in our study had no previous experience of the LCP and, 
apart from the three dedicated palliative care units, had no specialist palliative care support. 
Training in the use of the LCP and support for its implementation used a standardised 
approach provided centrally by palliative care clinical training experts with the support of the 
WA Country Health Service.   
Strengths and Limitations of the Study.  This study aimed to address some of the 
methodological issues encountered by previous research. First, our study evaluated the LCP 
as it was implemented in practice within the state health services, using a quality 
improvement training process that supported providers throughout the demonstration with 
continuous education, quality improvement problem-solving techniques, and monthly 
coaching calls to address problems in the field. Second, we used a Pre/Post intervention 
design with an added contemporaneous comparison group of patients who died within these 
organizations during the intervention period but did not receive the intervention. This design 
allowed for the evaluation of any secular trends in clinical care that could have influenced the 
implementation of the LCP. This comparison group provides added efficacy to the evaluation 
design.    Third, while much of the LCP literature focuses on cancer deaths, this study 
included patients dying from both cancer and non-cancer diagnoses and was conducted over 
multiple types of service providers and care settings. Finally, our study focused on relevant 
clinical care processes directed at dying patients, looking for improvements in individual 
patient outcomes that would be clinically and personally meaningful to both patients and their 
families.   
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Nevertheless, our study also has limitations. First, participants were not randomised to 
intervention and/or control groups. This was due to the fact that the study was an evaluation 
of the LCP as implemented at specific sites, which were determined by the WA Department 
of Health. As a result, randomisation was not practical or feasible. Therefore, a Pre/Post 
intervention design, together with a contemporaneous control cohort and quality 
improvement implementation process, was used to address the clinical and service delivery 
questions identified in this study. Under the circumstances, we believe that this was the best 
design that was achievable. 
Second, we relied upon patient records to ascertain the care provided to patients.  
Medical record review is highly dependent on the accuracy, completeness, and legibility of 
patient records. A particular focus of the LCP is the documentation of care.  Thus, some 
outcomes, particularly communication, may have been under-reported in the Pre and Not-
LCP groups. However, most outcomes of interest in this study, i.e., clinical care and 
procedures or investigations in the last days of life, require specific data documented in the 
patient’s medical record. The alternative would have been to rely on carers’ or bereaved 
family members’ recall of care provided to the patients in the last days of life. Such recall is 
subject to response and recall bias and is likely to be less accurate than the written record in 
the patients’ files.    
Third, our study was set in sparsely populated rural areas, in which the availability of 
intensive invasive procedures may have been limited. Therefore, the findings may not be 
generalizable to all rural or to urban settings nor to improved health service delivery system-
wide.  Furthermore, the sparseness of the population meant that no single site had a sample 
size that was sufficient to assess the implementation of the LCP. Even after collecting all 
available data from 13 sites, the overall number of eligible deaths in the reference periods 
was lower than anticipated. These differences can be attributed to the fact that the number of 
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deaths at a given site in a given period cannot be accurately predicted. As a result, there was 
insufficient statistical power to control for differences in care practices across sites or for 
different diagnoses, in the naïve analysis presented here. The results should therefore be 
interpreted with caution, pending more sophisticated statistical modelling.  
Finally, while extensive efforts were made throughout the implementation period to 
support and educate clinicians on the appropriate use of the LCP, we were unable to directly 
assess the manner in which the LCP was interpreted and then applied by the clinical teams in 
the implementation organizations. Based on the intensive quality improvement education 
sessions conducted over the course of the demonstration, the assumption was made that the 
LCP was implemented approximately the same way across all the sites.  
New interventions need to be critically evaluated to assess benefits and risks; 
nevertheless, innovation is necessary to meet the challenges of providing optimal care for the 
dying in the future. [40]  The WA Health Department addressed this dilemma by first pilot 
testing the LCP in four palliative care settings before testing the LCP in the larger project in 
the 13 rural settings reported here. However, this study does not address some of the 
major unanswered questions in the literature. These include: developing a firmer 
understanding of the content and process of the clinical team discussions initiating the LCP 
(e.g., clinical team discussions; communication with the family) as well as a better 
understanding whether it is the content of the LCP training itself or the quality improvement 
implementation process that contributes most to the successful implementation of the 
pathway. 
CONCLUSION 
This study supports the conclusion that a structured, centralised and directed 
implementation of the LCP can be successful in improving important aspects of clinical and 
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